Skip to main content
. 2020 Jun 25;8(1):e000491. doi: 10.1136/jitc-2019-000491

Figure 6.

Figure 6

ImmuneCluster classification and response to immunotherapy. (A) Kaplan-Meier curve showing survival after immunotherapy treatment in metastatic melanoma. High ImmuneCluster and Medium ImmuneCluster samples exhibited a tendency toward better overall survival than Low ImmuneCluster samples (Log-rank test, p=0.084). (B) Frequency of metastases in each ImmuneCluster by location.